AI Compound Screening for Synergistic Combination Therapy
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for developing combination therapies are labor-intensive, time-consuming, and fail to integrate knowledge from diverse disciplines, making it difficult to identify synergistic natural compounds that enhance efficacy, reduce toxicity, and overcome drug resistance.
Innovation Solution
An AI-driven system that processes vast amounts of data to analyze and identify synergistic blends of natural compounds by leveraging generative AI agents, clinical evidence, and machine learning algorithms, bridging gaps between naturopathic, traditional Chinese, Ayurvedic, pharmacological, and digital technologies.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If traditional manual methods are used to identify compounds for combination therapy, then the process allows for careful analysis and validation, but the process becomes labor-intensive and time-consuming
Solution Approach 1:
The patent introduces an AI-driven system as an intermediary between researchers and compound analysis. This system processes vast amounts of data from multiple disciplines (naturopathic medicine, traditional Chinese medicine, Ayurvedic medicine, pharmacology, organic chemistry, radiology, and digital technology) to identify synergistic compounds, thereby reducing manual labor while maintaining analysis accuracy through multiple validation layers
Solution Approach 2:
The patent segments the complex compound identification process into distinct AI-driven modules: data collection from diverse sources, preliminary screening for synergistic effects, mechanism of action analysis, pharmacokinetics evaluation, and clinical evidence validation. This segmentation enables parallel processing of multiple compounds simultaneously, reducing overall time while maintaining comprehensive analysis
2Quantity of substance
If traditional methods are used to evaluate compounds, then resource requirements are manageable, but the ability to process vast amounts of data is limited
Solution Approach 1:
The patent replaces manual mechanical review processes with AI-driven computational systems. The AI system automatically processes vast amounts of data from multiple disciplines, performing preliminary screening, identifying synergistic effects, and evaluating mechanisms of action without requiring proportional increases in human resources, thus managing resource requirements while dramatically increasing data processing capacity
3Adaptability or versatility
If a siloed approach is used to develop combination therapies, then the process remains simple and focused, but knowledge from diverse disciplines is not integrated
Solution Approach 1:
The patent creates a universal AI-driven platform that handles multiple functions: collecting data from diverse disciplinary sources, analyzing synergistic effects across different medicine systems, evaluating pharmacological mechanisms, and validating clinical evidence. This multi-functional system integrates knowledge from naturopathic medicine, traditional Chinese medicine, Ayurvedic medicine, pharmacology, organic chemistry, radiology, and digital technology within a single cohesive framework
Data Source
AI summary
A system and method are herein disclosed. The system and method use a generative AI agent to analyze and identify synergistic blends of natural compounds for combination therapies by leveraging an array of specialized modes to access data from a multitude of sources including patient medical history (including test results, drug history, and imaging) to improve the efficacy of compounds, including traditional medicine, in line with combination therapy principles, aimed at: enhanced efficacy, decreased toxicity, improved dosage, and reduced drug resistance. In this way, the generative AI agent determines cross-therapeutic similarities and/or dissimilarities between pharmaceutical, naturopathic, homeopathic, and nutraceutical compounds along a plurality of compound property vectors such as efficiency, efficacy, toxicity, effects, side-effects, chemistry, pharmacology, pharmacokinetics, mechanisms of action, and pharmacodynamics, thereby enabling the proposition of cross-disciplinary and transdisciplinary therapeutic analyses and the identification of synergistic effects in combination therapies.